Influence of 5‐Alpha Reductase Inhibitors on PI‐RADS Scores and Prostate Cancer Detection: A Systematic Review and Meta‐Analysis
The Prostate · 2026
DOI: 10.1002/pros.70066 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift The Prostate, 2026. Verfasst von Lian Qiong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Lanzhou University Second Hospital, Lanzhou, Gansu, P.R. China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, 5-alpha Reductase Inhibitors, Prostate. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Background
The impact of 5‐alpha reductase inhibitors (5‐ARIs) on Prostate Imaging Reporting and Data System (PI‐RADS) tumor classifications and prostate cancer (PCa) detection were reviewed and analyzed.
Method
A comprehensive systematic review and meta‐analysis were conducted by evaluating published studies examining the influence of 5‐ARIs on PI‐RADS lesions and PCa detection. The Web of Science, PubMed, and Embase databases were accessed for relevant study retrieval. Statistical analyses were performed through the use of STATA v.16.0.
Results
Seven studies, comprising 12,132 participants, were included. Compared to men who had not received 5‐ARIs, those exposed to 5‐ARIs exhibited no significant differences in PCa diagnosis (OR 0.97, 95% CI 0.86–1.08; p = 0.55) or clinically significant PCa (csPCa) diagnosis (OR 1.01, 95% CI 0.89–1.16; p = 0.85). Further subgroup analyses demonstrated that 5‐ARI‐exposed men had comparable PCa diagnosis in PI‐RADS 3 (OR 0.85, 95% CI 0.65–1.12; p = 0.25), PI‐RADS 4 (OR 1.01, 95% CI 0.85–1.21; p = 0.84), and PI‐RADS 5 (OR 1.01, 95% CI 0.81–1.26; p = 0.87) groups relative to 5‐ARI‐naïve men.
Conclusions
These findings suggest that 5‐ARIs do not significantly alter PI‐RADS lesion distribution or impact PCa and csPCa diagnosis. Consequently, exposure to 5‐ARIs should not influence MRI‐based diagnostic approaches in patients with suspected PCa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Lanzhou University Second Hospital, Lanzhou, Gansu, P.R. China.
- Department of general surgical, The People's Hospital of Guazhou County, Jiuquan, Gansu, P.R. China.
- Department of Urology, Gansu Provincial Hospital, Lanzhou, Gansu, P.R. China.
ORCID-Profile: Liu Qiangzhao
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Qiong, L., Qingyi, L., Bohong, G., YouCheng, H., & Qiangzhao, L. (2026). Influence of 5‐Alpha Reductase Inhibitors on PI‐RADS Scores and Prostate Cancer Detection: A Systematic Review and Meta‐Analysis. The Prostate. https://doi.org/10.1002/pros.70066
Vancouver
Qiong L, Qingyi L, Bohong G, YouCheng H, Qiangzhao L. Influence of 5‐Alpha Reductase Inhibitors on PI‐RADS Scores and Prostate Cancer Detection: A Systematic Review and Meta‐Analysis. The Prostate. 2026. doi:10.1002/pros.70066
BibTeX
@article{Qiong2026,
author = {Qiong, Lian and Qingyi, Li and Bohong, Guo and YouCheng, Hao and Qiangzhao, Liu},
title = {Influence of 5‐Alpha Reductase Inhibitors on PI‐RADS Scores and Prostate Cancer Detection: A Systematic Review and Meta‐Analysis},
journal = {The Prostate},
year = {2026},
doi = {10.1002/pros.70066}
}
EUVIMED